NRx Pharmaceuticals, Inc. (NRXP) Misses Q1 EPS by 2c

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics